IRIS Accounts Production v26.2.0.496 08223813 director 1.1.25 31.12.25 31.12.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh082238132024-12-31082238132025-12-31082238132025-01-012025-12-31082238132023-09-30082238132023-10-012024-12-31082238132024-12-3108223813ns15:EnglandWales2025-01-012025-12-3108223813ns14:PoundSterling2025-01-012025-12-3108223813ns10:Director12025-01-012025-12-3108223813ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3108223813ns10:SmallEntities2025-01-012025-12-3108223813ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3108223813ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3108223813ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3108223813ns10:FullAccounts2025-01-012025-12-3108223813ns10:CompanySecretary12025-01-012025-12-3108223813ns10:RegisteredOffice2025-01-012025-12-3108223813ns5:CurrentFinancialInstruments2025-12-3108223813ns5:CurrentFinancialInstruments2024-12-3108223813ns5:ShareCapital2025-12-3108223813ns5:ShareCapital2024-12-3108223813ns5:RetainedEarningsAccumulatedLosses2025-12-3108223813ns5:RetainedEarningsAccumulatedLosses2024-12-3108223813ns5:PlantMachinery2025-01-012025-12-3108223813ns5:FurnitureFittings2025-01-012025-12-3108223813ns5:ComputerEquipment2025-01-012025-12-3108223813ns5:PlantMachinery2024-12-3108223813ns5:FurnitureFittings2024-12-3108223813ns5:ComputerEquipment2024-12-3108223813ns5:PlantMachinery2025-12-3108223813ns5:FurnitureFittings2025-12-3108223813ns5:ComputerEquipment2025-12-3108223813ns5:PlantMachinery2024-12-3108223813ns5:FurnitureFittings2024-12-3108223813ns5:ComputerEquipment2024-12-3108223813ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3108223813ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3108223813ns10:Director112024-12-3108223813ns10:Director112023-09-3008223813ns10:Director112025-01-012025-12-3108223813ns10:Director112023-10-012024-12-3108223813ns10:Director112025-12-3108223813ns10:Director112024-12-31
REGISTERED NUMBER: 08223813 (England and Wales)










UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2025

FOR

DERMA CLINIC LIMITED

DERMA CLINIC LIMITED (REGISTERED NUMBER: 08223813)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


DERMA CLINIC LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2025







DIRECTOR: Dr N Christophorou





SECRETARY: Dr N Christophorou





REGISTERED OFFICE: 8 The Square
Caterham
Surrey
CR3 6XS





REGISTERED NUMBER: 08223813 (England and Wales)





ACCOUNTANTS: Beavis Morgan LLP
869 High Road
London
N12 8QA

DERMA CLINIC LIMITED (REGISTERED NUMBER: 08223813)

STATEMENT OF FINANCIAL POSITION
31 DECEMBER 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,716 2,560

CURRENT ASSETS
Debtors 5 72,745 102,833
Cash at bank 3,109 3,327
75,854 106,160
CREDITORS
Amounts falling due within one year 6 144,302 82,016
NET CURRENT (LIABILITIES)/ASSETS (68,448 ) 24,144
TOTAL ASSETS LESS CURRENT
LIABILITIES

(66,732

)

26,704

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (66,733 ) 26,703
SHAREHOLDERS' FUNDS (66,732 ) 26,704

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 September 2026 and were signed by:





Dr N Christophorou - Director


DERMA CLINIC LIMITED (REGISTERED NUMBER: 08223813)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1. STATUTORY INFORMATION

Derma Clinic Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The financial statements have been prepared on a going concern basis.

Turnover
Turnover represents gross invoiced sales of services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on cost
Fixtures and fittings - 25% on reducing balance
Computer equipment - 25% straight line method

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

DERMA CLINIC LIMITED (REGISTERED NUMBER: 08223813)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2025

4. TANGIBLE FIXED ASSETS
Fixtures
Plant and and Computer
machinery fittings equipment Totals
£    £    £    £   
COST
At 1 January 2025
and 31 December 2025 87,795 16,207 6,020 110,022
DEPRECIATION
At 1 January 2025 87,795 14,281 5,386 107,462
Charge for year - 482 362 844
At 31 December 2025 87,795 14,763 5,748 108,306
NET BOOK VALUE
At 31 December 2025 - 1,444 272 1,716
At 31 December 2024 - 1,926 634 2,560

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Other debtors 72,745 102,833

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade creditors 83,936 53,090
Taxation and social security 8,069 4,621
Other creditors 52,297 24,305
144,302 82,016

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 31 December 2025 and the period ended 31 December 2024:

2025 2024
£    £   
Dr N Christophorou
Balance outstanding at start of year 60,437 60,219
Amounts advanced 1,285 1,662
Amounts repaid (14,115 ) (1,444 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 47,607 60,437

During the period under review, interest amounting to £1,285 (2025: £Nil) was charged on the loan to director.